| BCL-2 family isoforms in apoptosis and cancer CFA Warren, MW Wong-Brown, NA Bowden Cell death & disease 10 (3), 177, 2019 | 637 | 2019 |
| Panel testing for familial breast cancer: calibrating the tension between research and clinical care ER Thompson, SM Rowley, N Li, S McInerny, L Devereux, ... Journal of Clinical Oncology 34 (13), 1455-1459, 2016 | 212 | 2016 |
| Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer MW Wong-Brown, CJ Meldrum, JE Carpenter, CL Clarke, SA Narod, ... Breast cancer research and treatment 150, 71-80, 2015 | 156 | 2015 |
| No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing DF Easton, F Lesueur, B Decker, K Michailidou, J Li, J Allen, C Luccarini, ... Journal of medical genetics 53 (5), 298-309, 2016 | 144 | 2016 |
| BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer MW Wong, C Nordfors, D Mossman, G Pecenpetelovska, KA Avery-Kiejda, ... Breast cancer research and treatment 127, 853-859, 2011 | 144 | 2011 |
| The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome KA Avery-Kiejda, B Morten, MW Wong-Brown, A Mathe, RJ Scott Carcinogenesis 35 (3), 586-596, 2014 | 118 | 2014 |
| Novel genes associated with lymph node metastasis in triple negative breast cancer A Mathe, M Wong-Brown, B Morten, JF Forbes, SG Braye, ... Scientific reports 5 (1), 15832, 2015 | 59 | 2015 |
| DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients A Mathe, M Wong-Brown, WJ Locke, C Stirzaker, SG Braye, JF Forbes, ... Scientific reports 6 (1), 33435, 2016 | 54 | 2016 |
| Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls ER Thompson, KL Gorringe, SM Rowley, MW Wong-Brown, S McInerny, ... Breast Cancer Research 17, 1-11, 2015 | 51 | 2015 |
| Reevaluation of the BRCA2 truncating allele c.9976A > T (p.Lys3326Ter) in a familial breast cancer context ER Thompson, KL Gorringe, SM Rowley, N Li, S McInerny, ... Scientific reports 5 (1), 14800, 2015 | 49 | 2015 |
| Gastrointestinal polyps in McCune Albright syndrome M Zacharin, A Bajpai, CW Chow, A Catto-Smith, C Stratakis, MW Wong, ... Journal of medical genetics 48 (7), 458-461, 2011 | 43 | 2011 |
| Targeting DNA repair in ovarian cancer treatment resistance MW Wong-Brown, A van der Westhuizen, NA Bowden Clinical Oncology 32 (8), 518-526, 2020 | 32 | 2020 |
| Mutations in RECQL are not associated with breast cancer risk in an Australian population N Li, SM Rowley, DL Goode, KC Amarasinghe, S McInerny, L Devereux, ... Nature genetics 50 (10), 1346-1348, 2018 | 28 | 2018 |
| Methyl-donor and cofactor nutrient intakes in the first 2–3 years and global DNA methylation at age 4: a prospective cohort study RM Taylor, R Smith, CE Collins, D Mossman, MW Wong-Brown, EC Chan, ... Nutrients 10 (3), 273, 2018 | 24 | 2018 |
| Reevaluation of RINT1 as a breast cancer predisposition gene N Li, ER Thompson, SM Rowley, S McInerny, L Devereux, D Goode, ... Breast cancer research and treatment 159, 385-392, 2016 | 24 | 2016 |
| Low prevalence of germline PALB2 mutations in Australian triple‐negative breast cancer MW Wong‐Brown, KA Avery‐Kiejda, NA Bowden, RJ Scott International journal of cancer 134 (2), 301-305, 2014 | 24 | 2014 |
| Epigenetic mechanisms and therapeutic targets in chemoresistant high-grade serous ovarian cancer BG Matthews, NA Bowden, MW Wong-Brown Cancers 13 (23), 5993, 2021 | 23 | 2021 |
| The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and … BC Morten, MW Wong-Brown, RJ Scott, KA Avery-Kiejda Carcinogenesis 37 (1), 81-86, 2016 | 21 | 2016 |
| Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study N Li, BWX Lim, ER Thompson, S McInerny, M Zethoven, D Cheasley, ... NPJ Breast Cancer 7 (1), 76, 2021 | 16 | 2021 |
| Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy MW Wong-Brown, A van der Westhuizen, NA Bowden BMC cancer 22 (1), 100, 2022 | 12 | 2022 |
Rodney J ScottProfessor of GeneticsVerified email at newcastle.edu.au